Series B Funding
Series B funding is a growth-stage equity round raised to scale a business that has already proven its model. The round expands the team, market reach, sales capacity, and revenue engine, with investors focused on growth efficiency and a clear path to market leadership rather than on finding product-market fit (which should already be established). It's where the focus shifts from "find what works" to "scale what works."
The 2025 benchmarks (Carta and PitchBook):
| Metric | 2025 typical range | Notes |
|---|---|---|
| Round size | $30M-$40M | $40M-$80M for hot sectors or larger ARR companies |
| Post-money valuation | $120M-$160M (median ~$135M) | Down from $200M+ peaks in 2021 |
| Pre-money valuation | $90M-$130M | After pool refresh |
| Founder dilution | 15-18% | Lower percentage than Series A because round is larger relative to valuation |
| Option pool top-up | 12-15% post-money | Smaller refresh than at A |
| ARR threshold | $5M-$10M | With 80-120% YoY growth |
| Time from Series A | ~24 months (stretched from ~18 months pre-2022) | Carta 2026 |
What investors require at Series B:
- ARR scale: $5M-$10M ARR with 80-120% YoY growth. Some sectors have higher bars ($10M-$15M for enterprise SaaS Series B).
- Growth efficiency: Rule of 40 trending toward positive (growth % + EBITDA margin >40); burn multiple <2x; capital efficiency improving.
- Market position: clear category leadership signals (top 3 in category, customer references, competitive wins).
- Unit economics: LTV:CAC >4, CAC payback <18 months for SMB, <24 months for mid-market.
- Sales motion: repeatable sales process, defined ICP, predictable pipeline conversion.
- Executive team: CFO, VP Sales, VP Engineering at minimum; some have VP Marketing and VP Product as well.
Who leads Series B rounds:
- Same Series A investors going up-round: Sequoia, a16z, Accel, etc. extending position.
- Growth-stage funds entering at B: Lightspeed, Coatue, Tiger Global, Insight, IVP, Bessemer, ICONIQ.
- Crossover investors: T. Rowe Price, Fidelity, BlackRock, Wellington (more common at C+, but appears at large B rounds).
- Strategic / corporate investors: increasing presence at B in vertical-specific deals (Microsoft for AI, Salesforce Ventures for SaaS, etc.).
The 2021-vintage problem (still active in 2025):
Companies that raised Series B at peak valuations in 2021-2022 are facing the reality at Series C that valuations have compressed substantially. A Series B closed at $300M post-money in 2021 might be facing a C in 2025-2026 priced at $200M-$300M, a flat or modest down round at best. The phrase "the year of the down round" applied to 2023-2024 and the residual still shapes 2025 conversations.
Flat and down rounds at B/C are no longer career-ending:
- Pre-2022: a flat or down round was treated as failure.
- Post-2022: investors and founders both accept that 2021-vintage valuations were inflated. Flat is the new up; modest down isn't fatal.
- Pay-to-play provisions and protective provisions become more common at down B/C rounds.
Ryan's Take
Series B is "you proved it works, now prove it scales." The trap is treating the cash as permission to spend instead of fuel for a machine that already converts. If your unit economics only work on a slide, a big B just helps you lose money faster. And if you raised a frothy A in 2021 or 2022, your B might be flat or even down. That's not failure. It's arithmetic. Plan for it now so it doesn't ambush you in the term sheet. The discipline that works: Rule of 40 trending positive, burn multiple under 2x, repeatable sales motion with predictable pipeline, clear market-leader signals. The discipline that fails: raising a B to fund growth-at-any-cost; treating the round as success rather than fuel; failing to lock in efficient growth before the round.
What founders get wrong (specific failure mode): Series A company raised at $80M post-money in 2022 with $1.5M ARR. By Series B in 2025, the company is at $7M ARR with 95% growth, solid metrics. But Series B investors are pricing at $130M post-money (typical for 2025 metrics), which is below the $200M+ post-money the founder was anchored on from the 2022 peak. Founder spends 5 months pushing back on valuation, multiple term sheets come in similar range, eventually accepts $135M post-money. The "down" feeling sours the round emotionally, but the company is actually doing well. The right discipline: accept that 2025 valuations are different from 2021 valuations; metrics matter more than the previous round's price.
Related: Series A Funding · Series C Funding · Down Round · Flat Round · ARR · Rule of 40
FAQ
How much is a Series B round?
2025 typical: $30M-$40M at $120M-$160M post-money. Hot sectors or larger ARR companies reach $40M-$80M. Founder dilution typically 15-18%, lower percentage than Series A because round size is larger relative to valuation.
What do you need to raise a Series B?
$5M-$10M ARR with 80-120% YoY growth, healthy unit economics (LTV:CAC >4, CAC payback <18-24 months), Rule of 40 trending positive, burn multiple <2x, clear market-leader signals, full executive team.
What is the difference between Series A and Series B?
Series A funds scaling a proven model from $1-2M ARR to $5-10M. Series B funds aggressive expansion of that model from $5-10M ARR to $20-40M. Series A is "we have PMF, fund the scaling"; Series B is "scaling is working, fund the market capture."
What about 2021-vintage companies facing today's valuations?
Many 2021-vintage Series A/B companies are facing flat or down rounds in 2025. This is no longer career-ending, investors and founders accept that 2021-2022 valuations were inflated. Pay-to-play provisions and protective provisions are more common in down rounds at this stage.
Find this article helpful?
This is just a small sample! Register to unlock our in-depth courses, hundreds of video courses, and a library of playbooks and articles to grow your startup fast. Let us Let us show you!
Submission confirms agreement to our Terms of Service and Privacy Policy.